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In the last decade, the incidence of
Salmonella Enteritidis infections has increased
in many countries. In Europe, this serotype now
predominates among Salmonella isolates from
humans (1). In southern Italy, identification of S.
Enteritidis has increased steadily since 1990, in
parallel with increases throughout Europe. After
a temporary decline in 1995 and 1996, isolation
rates from both sporadic cases and foodborne
outbreaks increased. During 1998, records from
the Center for Enteric Pathogens in southern
Italy show identification rates of approximately
45% in all human Salmonella isolates and 61% in
isolates from patients hospitalized for enteritis.
In the Enteritidis serotype, resistance to
antimicrobial drugs is rare, but resistance to
antibacterial agents has been increasing in some
Mediterranean countries (2).
We conducted a retrospective study of
antimicrobial drug resistance patterns of S.
Enteritidis isolates identified from human,
animal, and environmental sources in southern
Italy from 1990 to 1998. We also investigated
mechanisms of resistance at the molecular level.
The Study
From 1990 to 1998, 1,889 strains of S.
Enteritidis were referred to the Center for
Enteric Pathogens, Palermo, southern Italy: 86%
were of human origin, 2.9% from infected animals
(mainly poultry), 6.7% from sewage plant
effluents and surface water, and 4.4% from foods
(mainly eggs and egg-based dishes). All strains
were biochemically identified by standard tests
and were serotyped for somatic and flagellar
antigen identification. Phage types were deter-
mined with 10 typing phages (3).
Forty-four (2.2%) of the 1,889 strains tested
were resistant to at least one antibiotic; we
examined patterns of antibiotic resistance, phage
types, and plasmid profiles of these 44 strains
(Table). Resistance to ampicillin, alone or
associated with other ß-lactams, and tetracy-
cline, alone orassociated with aminoglycosides,
sulfonamides, and trimethoprim, were the most
commonly encountered phenotypes among the S.
Enteritidis isolates studied. Of the 17 tetracy-
cline-resistant strains, nine and eight, respec-
tively, had transferrable plasmids of 80 and 30
MDal.
Six strains isolated from pediatric patients
with enteritis (three in 1992, 1994, and 1996 in
Sicily and three in 1997 in Calabria) were
resistant to ampicillin, aztreonam, cephalotin,
third-generation cephalosporins, and sulfona-
mides by the Kirby-Bauer method (7). Two of the
1997 isolates were also resistant to chloram-
phenicol. The double-disk synergy test was
positive for all six isolates, suggesting the
production of ESBL. In five cases, plasmids of 38,
70, and 80 MDa were shown by conjugation to
mediate the complete pattern of resistance. In
one strain identified in 1992, a 30-MDal plasmid
was detected, but the resistance traits could not
be transferred to recipient cells.
Six isolates of S. Enteritidis carried integrons
with inserted regions of DNA of 0.8 to 2.5 kb
(Table). Transconjugant Escherichia coli from
these strains was also positive, indicating that
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Table. Resistance patterns of Salmonella Enteriditis strains, southern Italy, 1990–1998
Resistance
Plasmid  pattern of  Integrons
 pattern   recipient   (size of
Phage Resistance (mol. wt., Escherichia   inserted
Year Source Region  types   patterna   MDa)      coli regions, kb)
1990 human Sicily RDNC Ap 36, 25
1991 cakeb Sicily 4 Su, Tp, Tc 80,c 36 Tp, Tc 2.5
1992 seafood Apulia 4 Ap 30 Ap
1992 seafood Apulia 4 Ap 36, 30 Ap
1992 human Sicily 4 Ap, Kf, Atm, Caz, Cro, Ctx, Su 30
1992 dog Sicily RDNC Ap, Kf, Sm, Su, Tc 30 Ap, Sm, Su, Tc
1992 human Calabria 4 Gm, Sm, Su 80, 70 0.8
1992 human Sicily RDNC Sm, Su, Tp 80, 36 Sm, Su, Tp
1992 human Calabria 1 Su, Tp, Tc 80, 36 Tp, Tc 1.5
1993 human Calabria 7 Gm, Sm, Tc 80 Tc
1993 human Sicily 4 Sm, Tc 80, 36 Tc
1993 human Sicily 4 Sm, Su, Tp, Tc 80, 36 Sm, Su, Tp, Tc
1993 human Sicily 7 Sm, Su, Tp, Tc 80, 36 Sm, Su, Tp, Tc
1994 human Sicily 4 Ap, Kf, Atm, Caz, Cro, Ctx, Su 80, 36 Ap, Kf, Atm, Caz, Cro, Ctx 2.0
1994 human Sicily RDNC Tc 36, 30 Tc
1994 human Sicily 4 Tc 36, 30 Tc
1995 human Calabria 4 Tc 36, 30 Tc
1995 human Apulia 4 Tc 80, 36 Tc
1995 human Apulia 7 Tc 36, 30 Tc
1996 human Sicily 4 Ap, Kf, Atm, Caz, Cro, Ctx, Su 80, 36 Ap, Kf, Atm, Caz, Cro, Ctx 2.0
1996 humanb Sicily RDNC Tc 36, 30 Tc
1996 human Apulia RDNC Tc 30 Tc
1997 human Sicily 4 Ap 36, 30
1997 human Sicily 4 Ap 36
1997 human Sicily 1 Ap 36, 30
1997 human Calabria 4 Ap, Kf, Atm, Caz, Cro, Ctx, Cm, Su 70, 36 Ap, Kf, Atm, Caz, Cro, Ctx, Cm
1997 human Calabria 4 Ap, Kf, Atm, Caz, Cro, Ctx, Cm, Su 38, 36 Ap, Kf, Atm, Caz, Cro, Ctx, Cm
1997 human Calabria RDNC Ap, Kf, Atm, Caz, Cro, Ctx, Cm, Su 80, 36 Ap, Kf, Atm, Caz, Cro, Ctx 2.0
1997 human Apulia 1 Ap, Sm, Tc 36, 30 Ap, Sm, Tc
1997 human Calabria 1 Ap, Sm, Tc 36, 32 Ap, Sm, Tc
1997 human Sicily 4 Cm, Su, Tp 36, 32 Cm, Su, Tp
1997 human Sicily 4 Su, Tp 36
1997 poultry Sicily 14b Tc 80, 36 Tc
1997 human Sicily 14b Tc 80 Tc
1997 human Sicily NT Tc 80 Tc
1997 human Sicily 13 Tc 80, 36 Tc
1997 human Sicily RDNC Tc, Nal 80, 36 Tc
1998 human Sicily 4 Ap 70, 36 Ap
1998 sewage Sicily RDNC Ap, Kf 36
1998 human Sicily RDNC Tc 36, 30 Tc
1998 human Sicily 7 Tc 30 Tc
1998 human Sicily 6a Tc 80, 36 Tc
1998 human Sicily RDNC Tc 36, 30 Tc
1998 poultry Sicily RDNC Tc 30 Tc
Ap, ampicillin; Kf, cephalotin; Atm, aztreonam; Caz, ceftazidime; Cro, ceftriaxone; Ctx, cefotaxime; Cm, chloramphenicol; Gm,
gentamicin; Sm, streptomycin; Su, sulfonamides; Tp, trimethoprim; Tc, tetracycline; Nal, nalidixic acid; RDNC, reaction did
not conform; NT, not typable.
aThe strains were screened for resistance to ampicillin (10 µg), cephalotin (30 µg), cefotaxime (30 µg), chloramphenicol (30 µg),
ciprofloxacin (5 µg), gentamicin (10 µg), nalidixic acid (30 µg), streptomycin (10 µg), sulfonamides (300 µg), tetracycline (30 µg),
and trimethoprim (5 µg). Strains resistant to cefotaxime were subsequently tested for susceptibility to aztreonam (30 µg),
ceftazidime (30 µg), and ceftriaxone (30 µg). Resistance was determined by disk diffusion (4). The double-disk synergy test was
performed (4) on strains presumed to produce extended-spectrum ß-lactamase (ESBL). Plasmid DNA was extracted by an
alkaline lysis method (5). Electrophoresis on 0.7% agarose gels was performed on samples of plasmid DNA. The approximate
molecular weight of plasmids was estimated by comparison with plasmids of known molecular size extracted from Escherichia
coli. Conjugation experiments were carried out in Luria-Bertani broth. Transconjugant colonies of E. coli were selected after
growth on MacConkey agar containing rifampin (300 µg/ml) and ampicillin (50 µg/ml), streptomycin (30 µg/ml),
chloramphenicol (30 µg/ml), or tetracycline (30 µg/ml). All resistant isolates were screened for class I integrons by a strict
protocol with oligonucleotide primers specific for the sequence of the 5'-CS and 3'-CS regions adjacent to the site-specific
recombinational insertion sequence (6). Primer sequences were 5'-CS, GGCATCCAAGCAGCAAG and 3'-CS,A
AGCAGACTTGACCTGA (5).
bSource in outbreak.
cNumbers in bold indicate the approximate molecular size of resistance plasmids.Dispatches
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the integrons were carried on plasmids. DNA
fragments of approximately 2.0 kb were obtained
from ESBL-producing strains.
Conclusions
During the 9-year study, a small proportion
of resistant strains was found within Enteritidis,
2.3% showing resistance to at least one
antimicrobial drug and 0.9% to three or more.
Prevalence in southern Italy was similar to that
in other European countries, such as England
and Wales (8) and the Czech Republic (9);
however, it was lower than prevalence detected
from 1987 to 1993 in Greece, where up to 67.4% of
strains of S. Enteritidis from human and
nonhuman sources were resistant to antibiotics
and the resistance rate increased steadily until
1991 (2). No temporal trend or possible
association with source was investigated in
resistance patterns identified in southern Italy
because resistant strains are rare and usually
from human sources.
The unusual characteristics of antimicrobial
resistance of some S. Enteritidis isolates
highlight the problem of emergence of drug
resistance in a common serotype of Salmonella,
transmitted in popular food items and often
implicated in foodborne outbreaks. We identified
six ESBL-producing isolates from epidemiologi-
cally unrelated cases, a rare finding (10-12). All
six strains were isolated from community-
acquired enteritis cases in otherwise healthy
children, who had no recent history of
hospitalization or antimicrobial therapy. This
observation is not consistent with the hypothesis
that multidrug-resistant clones are selected or
resistance determinants are acquired as a
consequence of antibiotic treatment. Moreover,
the presence of integrons in strains isolated as
long ago as 1991 is of particular concern because
of the ability of these elements to disseminate
resistance traits by intra- and inter-specific gene
transfer (13,14).
Although most isolates identified in southern
Italy were susceptible, some aspects of the
epidemiology of S. Enteritidis are cause for
concern. Active monitoring of S. Enteritidis
strains for resistance to antibacterial drugs
seems crucial because of the public health
implications of a potential spread of resistant
clones.
Dr. Nastasi is a professor of hygiene at the depart-
ment of public health of the University of Florence, Italy.
He has been director of the Centre for Enteric Pathogens
of Southern Italy. His research interests include epide-
miology of infectious diseases and molecular epidemiol-
ogy of infections by enteric pathogens.
References
    1. Fisher J. Salm/Enter-Net records a resurgence in
Salmonella enteritidis infection through the European
Union. Eurosurveillance Weekly 1997;1:June 26.
    2. Tassios PT, Markogiannakis A, Vatopoulos AC,
Katsanikou E, Velonakis EN, Kourea-Kremastinou J,
et al. Molecular epidemiology of antibiotic resistance of
Salmonella enteritidis during a 7-year period in
Greece. J Clin Microbiol 1997;35:1316-21.
  3. Ward LR, De Sa JDH, Rowe B. A phage-typing scheme for
Salmonella enteritidis. Epidemiol Infect 1987;99:291-4.
  4. National Committee for Clinical Laboratory Standards.
Performance standards for antimicrobial disk
susceptibility tests for bacteria that grow aerobically.
Approved standard M7-A4. Villanova (PA): The
Committee; 1997.
    5. Birnboim HC, Doly J. A rapid alkaline extraction
procedure for screening recombinant plasmid DNA.
Nucleic Acids Res 1979;7:1513-23.
  6. Lévesque C, Piché L, Larose C, Roy PH. PCR mapping
of integrons reveals several novel combinations of
resistance genes. Antimicrob Agents Chemother
1995;39:185-1.
    7. Bauer AW, Kirby MMW, Sherris JC, Turck M.
Antibiotic susceptibility testing by a standardized
single disk method. Am J Clin Pathol 1966;45:493-6.
  8. Threlfall EJ, Ward LR, Skinner JA, Rowe B. Increase in
multiple antibiotic resistance in nontyphoidal
Salmonellas from human in England and Wales: a
comparison of data for 1994 and 1996. Microb Drug
Resist 1997;3:263-6.
    9. Sramova H, Karpiskova R, Dedicova D, Sisak F,
Rychlik I. Properties of Salmonella isolates in the Czech
Republic. Epidem Mikrobiol Immunol 1999;48:111-6.
10. Cherian BP, Singh N, Charles W, Prabhakar P.
Extended-spectrum beta-lactamase-producing
Salmonella enteritidis in Trinidad and Tobago. Emerg
Infect Dis 1999;5:181-2.
11. Blahova J, Lesicka-Hupkova M, Kralikova K,
Krcmerry V, Krcmeryova T, Kubonova K. Further
occurrence of extended-spectrum-beta-lactamase-
producing  Salmonella enteritidis. J Chemother
1998;10:291-4.
12. Gaillot O, Clement C, Simonet M, Philippon A. Novel
transferable beta-lactam resistance with
cephalosporinase characteristics in Salmonella
enteritidis. J Antimicrob Chemother1997;39:85-7.
13. Stokes H, Hall RA. A novel family of potential mobile
DNA elements encoding site-specific gene integration
functions: integrons. Mol Microbiol 1989;3:1669-83.
14. Rankin SC, Coyne MJ. Multiple antibiotic resistance in
Salmonella enterica serotype enteritidis. Lancet
1998;351:1740.